Genmab A/S
MONOCLONAL ANTIBODIES AGAINST HER2
Last updated:
Abstract:
Isolated monoclonal antibodies which bind to human epidermal growth factor receptor 2 (HER2), and related antibody-based compositions and molecules, are disclosed. Pharmaceutical compositions comprising the antibodies and therapeutic and diagnostic methods for using the antibodies are also disclosed.
Status:
Application
Type:
Utility
Filling date:
7 Jul 2021
Issue date:
2 Jun 2022